Non-Small Cell Lung Cancer — Targeting KRAS G12C

Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:

• Introduction (0:00)
• Best Option for Your Patient (1:28)
• Biological Considerations (6:26)
• KRAS G12C Inhibitors (11:33)
• Second-Line Treatment (13:02)
• Current Clinical Trials in the First-Line Metastatic Setting (32:18)
• Current Clinical Trials in the Localized Setting (49:52)
• Current Clinical Trials with New Treatment Combinations and Agents (53:51)

CME information and select publications